Ciliary neurotrophic factor implant - Microbot Medical

Drug Profile

Ciliary neurotrophic factor implant - Microbot Medical

Alternative Names: Ciliary neurotrophic factor implant -; CNTF implant -

Latest Information Update: 13 Dec 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator StemCells; University of Lausanne
  • Developer StemCells
  • Class Eye disorder therapies; Obesity therapies
  • Mechanism of Action Ciliary neurotrophic factor replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Amyotrophic lateral sclerosis

Most Recent Events

  • 28 Nov 2016 StemCells has been acquired by Microbot Medical
  • 24 May 2000 Discontinued-I for Amyotrophic lateral sclerosis in USA (Intracranial)
  • 28 Jan 1998 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top